Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Christopher C Chapman Jr Other companies: MIRA Pharmaceuticals, Inc. (Executive Chairman, Director · Aug 2, 2023 – Aug 17, 2023 · Past); Q/C Technologies, Inc. (President, Chief Med. Officer, Director · Apr 16, 2021 – Jun 7, 2023 · Past); Rock Creek Pharmaceuticals Inc (President, Director · Sep 22, 2006 – Dec 27, 2013 · Past) | CEO & Chairman, Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| Craig Eagle Other companies: OS Therapies Incorporated (Director · Since at least Jul 1, 2026); Guardant Health, Inc. (Chief Medical Officer · Since at least May 4, 2021); Q/C Technologies, Inc. (Director · Apr 16, 2021 – Jun 7, 2023 · Past) | Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| Michael Jerman Other companies: Alaunos Therapeutics, Inc. (Managing Partner of Hollywell Partners · Since at least Jul 15, 2025); Inhibitor Therapeutics Inc. (Director · Since at least Apr 1, 2024); MIRA Pharmaceuticals, Inc. (Director · Nov 14, 2023 – Mar 25, 2024 · Past) | Director · Feb 8, 2024 – Aug 27, 2024 · Past |
| Alan Weichselbaum Other companies: FinWise Bancorp (Director · Since at least Oct 6, 2022); MIRA Pharmaceuticals, Inc. (Chief Financial Officer · May 15, 2025 – May 15, 2025 · Past) | Chief Financial Officer · May 15, 2025 – May 15, 2025 · Past |
| Hugh McColl III Other companies: Westrock Coffee Company (Director · Since at least Aug 26, 2022); MIRA Pharmaceuticals, Inc. (Director · Aug 2, 2023 – Aug 2, 2023 · Past) | Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| Michelle Yanez Other companies: Inhibitor Therapeutics Inc. (Director · Since at least Dec 13, 2022); MIRA Pharmaceuticals, Inc. (Chief Financial Officer · Aug 2, 2023 – Dec 9, 2024 · Past) | Chief Financial Officer · Jun 18, 2024 – Aug 27, 2024 · Past |
| Andriy Mushak Other companies: MIRA Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jun 2, 2026) | Chief Financial Officer · Since at least Jun 3, 2026 |
| Bradley Kroenig Other companies: MIRA Pharmaceuticals, Inc. (Director · Aug 2, 2023 – Aug 2, 2023 · Past) | Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| Christos Nicholoudis Other companies: MIRA Pharmaceuticals, Inc. (Director · Aug 2, 2023 – Aug 17, 2023 · Past) | General Counsel, Director · Feb 8, 2024 – Feb 8, 2024 · Past |
| Edward Clouston MacPherson Other companies: MIRA Pharmaceuticals, Inc. (Director · Since at least Mar 13, 2024) | Director · Since at least Aug 8, 2024 |
| Erez Aminov Other companies: MIRA Pharmaceuticals, Inc. (Chairman of the Board and Chief Executive Officer · Since at least Aug 2, 2023) | Chairman and Chief Executive Officer · Since at least Aug 8, 2024 |
| Matthew Del Giudice Other companies: MIRA Pharmaceuticals, Inc. (Director · Since at least Mar 13, 2024) | Director · Since at least Aug 8, 2024 |
| Matthew Pratt Whalen Other companies: MIRA Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2024) | Director · Since at least Aug 8, 2024 |
| Nathen Fuentes Other companies: Lunai Bioworks Inc. (Chief Financial Officer · Jan 6, 2025 – Jan 21, 2025 · Past) | Chief Financial Officer · Feb 8, 2024 – Feb 8, 2024 · Past |
| Ned MacPherson Other companies: MIRA Pharmaceuticals, Inc. (Director · Since at least Nov 4, 2026) | Director · Since at least Nov 4, 2026 |
| Talhia Tuck Other companies: MIRA Pharmaceuticals, Inc. (Director · Aug 2, 2023 – Aug 2, 2023 · Past) | Director · Feb 8, 2024 – Feb 8, 2024 · Past |